Interacting Drugs |
Rivaroxaban vs CYP3A4 Inducers (Strong) |
Security Level |
 |
Mechanism |
CYP3A4 Inducers (Strong): May decrease the serum concentration of Rivaroxaban. |
Management |
Avoid concurrent use of rivaroxaban and strong CYP3A4 inducers when possible. If such a combination is used, the U.S. labeling recommends an increase in rivaroxaban dose; Canadian labeling does not make specific dose increase recommendations. |
Rivaroxaban vs CYP3A4 Inducers (Strong)
Post Review about Rivaroxaban vs CYP3A4 Inducers (Strong) Click here to cancel reply.
Other Interactions of CYP3A4 Inducers (Strong)
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.